Loading clinical trials...
Loading clinical trials...
The primary study hypotheses are that, without increasing doses of breakthrough medications or device intolerance, the Nometex™ device worn for 5-days beginning with the day of chemotherapy administra...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Christiana Care Health Services
Collaborators
NCT07169851 · Nausea, Vomiting, and more
NCT05838638 · Neoplasms, Chemotherapy-induced Nausea and Vomiting
NCT06120764 · Chemotherapy-induced Nausea and Vomiting, Pediatric Cancer
NCT07446439 · Nausea and Vomiting, Obesity
NCT07540169 · Stomach Cancer, Chemotherapy-induced Nausea and Vomiting, and more
Helen F. Graham Cancer Center
Newark, Delaware
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions